International Variability in the Epidemiology, Management, and Outcomes of CKD and ESKD: A Systematic Review.
International Variability in the Epidemiology, Management, and Outcomes of CKD and ESKD: A Systematic Review.
复制标题
DOI：
10.34067/kid.0000000000000335
复制
发表时间：
2024-01-01
期刊：
影响因子：
--
通讯作者：
Radhakrishnan J
中科院分区：
文献类型：
--
作者：
Freedberg DE;Segall L;Liu B;Jacobson JS;Mohan S;George V;Kumar R;Neugut AI;Radhakrishnan J
ESKD的患病率存在显著的全球差异。每个国家人均卫生保健支出的增加与ESKD护理的增加有关。治疗ESKD的方法在国际上可能因护理的可用性和其他因素而异。我们进行了一项系统回顾，以了解ESKD流行病学、管理和结局的国际差异。我们系统性地检索了PubMed中关于CKD和ESKD流行病学和管理的基于人群的研究。来自23个预先指定国家的人群水平数据符合纳入条件，如果它们与接受透析或肾移植治疗ESKD的患者有关。在可用时，使用政府网站从相关肾脏登记处识别和提取数据。收集的指标包括与ESKD的患病率和死亡率有关的指标;肾病学家的可用性;人均医疗保健支出;以及促红细胞生成素刺激剂的使用。我们获得了来自美国的数据;东欧七个国家;西欧，拉丁美洲和非洲各四个国家;亚洲三个国家。记录的ESKD每百万人口的患病率从3600（马来西亚）到67（塞内加尔）不等。与ESKD相关的年死亡率从31%（埃塞俄比亚和塞内加尔）到10%（英国）不等。每百万人口的肾病医生可用性从40（日本）到<1（南非）不等，并与人均医疗保健支出相关。与ESKD相关的肾脏护理的提供在各国之间差异很大。较高的人均医疗保健支出与肾脏护理的增加有关。然而，部分原因是肾脏疾病的记录差异很大，因此很难确定各国与ESKD相关的结局可能有何差异。
There is dramatic global variability in the prevalence of ESKD. Higher per capita health care spending in each country is associated with increased delivery of care for ESKD. Approaches to treating ESKD may vary internationally on the basis of the availability of care and other factors. We performed a systematic review to understand the international variability in ESKD epidemiology, management, and outcomes. We systematically searched PubMed for population-based studies of CKD and ESKD epidemiology and management. Population-level data from 23 predesignated nations were eligible for inclusion if they pertained to people receiving dialysis or kidney transplant for ESKD. When available, government websites were used to identify and extract data from relevant kidney registries. Measures gathered included those related to the prevalence and mortality of ESKD; the availability of nephrologists; per capita health care expenditures; and use of erythropoietin-stimulating agents. We obtained data from the United States; seven nations in Eastern Europe; four each in Western Europe, Latin America, and Africa; and three in Asia. The documented prevalence of ESKD per million population varied from a high of 3600 (Malaysia) to a low of 67 (Senegal). The annual mortality associated with ESKD varied from 31% (Ethiopia and Senegal) to 10% (the United Kingdom). Nephrologist availability per million population varied from 40 (Japan) to <1 (South Africa) and was associated with per capita health care expenditures. The delivery of kidney care related to ESKD varies widely among countries. Higher per capita health care spending is associated with increased delivery of kidney care. However, in part because documentation of kidney disease varies widely, it is difficult to determine how outcomes related to ESKD may vary across nations.
影响因子：
3.7
作者：
Gebrie, Mignote Hailu;Asfaw, Hussen Mekonnen;Bilchut, Workagegnehu Hailu;Lindgren, Helena;Wettergren, Lena
通讯作者：
Wettergren, Lena
慢性肾脏疾病的负担：北非。
影响因子：
5.5
作者：
Barsoum, Rashad S.
通讯作者：
Barsoum, Rashad S.